Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock

NCT07063680 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

390

Enrollment

OTHER

Sponsor class

Conditions

Patients With Norepinephrine-refractory Vasoplegic Shock

Interventions

DRUG: Argipressin
DRUG: Chlorure de sodium
OTHER: Collection of clinical data

Sponsor

Centre Hospitalier Universitaire Dijon